Abstract
A novel series of 4-chloro-3-arylmaleimide derivatives have been synthesized and evaluated for their cytotoxicity in vitro against human leukemia cell line and four human solid cancer cell lines. Most compounds showed high or mediate activity against the cancer cell lines when compared with bisindolylmaleimide. Among them, 4b is the most promising compound.
Keywords: 4-chloro-3-arylmaleimide, Synthesis, Antitumor activity
Related Journals
Current Drug Research Reviews
Current Computer-Aided Drug Design
Anti-Cancer Agents in Medicinal Chemistry
Current Drug Discovery Technologies
Central Nervous System Agents in Medicinal Chemistry
Current Medicinal Chemistry
The Natural Products Journal
CNS & Neurological Disorders - Drug Targets
Cardiovascular & Hematological Disorders-Drug Targets
Applied Drug Research, Clinical Trials and Regulatory Affairs
Related Books
Advances in Anticancer Agents in Medicinal Chemistry
Advances in Anticancer Agents in Medicinal Chemistry
Bioactive Phytochemicals: Drug Discovery to Product Development
Biologically Active Natural Products from Asia and Africa: A Selection of Topics
Endocannabinoids: Molecular, Pharmacological, Behavioral and Clinical Features
Medical Applications of Beta-Glucan
Nanotechnology Driven Herbal Medicine for Burns: From Concept to Application
Postbiotics: Science, Technology and Applications
Solubility, Delivery and ADME Problems of Drugs and Drug-Candidates
The Pharmaceutical Scientist Guide to Solution Kinetic Models Mathematical Description and Applications
48